Lyell Immunopharma's CEO Seely Lynn sells shares to cover tax obligations, reflecting the company's management of stock compensation and transparency.
| Name | Lyell Immunopharma, Inc. |
|---|---|
| CIK | 0001806952 |
| Tickers | LYEL |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 833006753 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 650 695-0677 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Lyell Immunopharma's CEO Seely Lynn sells shares to cover tax obligations, reflecting the company's management of stock compensation and transparency.
Lyell Immunopharma updates on substantial ownership by ARCH Venture Fund IX, indicating a shift in investment dynamics in the pharmaceutical sector.
Lyell Immunopharma, Inc. announces its Q3 financial results, showcasing its efforts in the competitive pharmaceutical preparations sector.
Lyell Immunopharma announces Q3 2026 financial results, showcasing advancements in CAR T-cell therapies and promising data from ongoing clinical trials.
Lyell Immunopharma has secured $80 million through a private placement of common stock, enhancing its financial strength in the pharmaceutical industry.
365 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-13 | S-3 | S-3 | 0001193125-26-460585 | 333-300032 | 261552306 | 33 | 359752 | 1 | 1 | |
| 2026-11-12 | 4 | xslF345X06/form4-11122026_091132.xml | 0001907345-26-000008 | 4906 | ||||||
| 2026-11-12 | 4 | xslF345X06/form4-11122026_091105.xml | 0001866154-26-000008 | 4928 | ||||||
| 2026-11-12 | 4 | xslF345X06/form4-11122026_091139.xml | 0001327111-26-000008 | 4870 | ||||||
| 2026-11-12 | 4 | xslF345X06/form4-11122026_091120.xml | 0002095702-26-000007 | 4950 | ||||||
| 2026-11-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001012975-26-001025 | 005-93402 | 261541904 | 34 | 28686 | |||
| 2026-11-05 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-001014 | 16947 | ||||||
| 2026-11-05 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-001013 | 22317 | ||||||
| 2026-11-04 | 10-Q | 10-Q | 0001628280-26-070171 | 001-40502 | 261522542 | 34 | 11788210 | 1 | 1 | |
| 2026-11-04 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-070161 | 001-40502 | 261522398 | 34 | 319812 | 1 | 1 |
| 2026-11-04 | 8-K | 8-K | 3.02 | 0001193125-26-446317 | 001-40502 | 261520315 | 34 | 136429 | 1 | 1 |
| 2026-10-13 | 4 | xslF345X06/form4-10132026_091052.xml | 0002150331-26-000003 | 5382 | ||||||
| 2026-09-10 | 4 | xslF345X06/form4-09102026_110937.xml | 0001959742-26-000003 | 5337 | ||||||
| 2026-09-10 | 4 | xslF345X06/form4-09102026_110951.xml | 0002150331-26-000002 | 6819 | ||||||
| 2026-09-10 | 3 | xslF345X06/form3-09102026_110902.xml | 0002150331-26-000001 | 14901 | ||||||
| 2026-09-10 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-387890 | 001-40502 | 261371241 | 34 | 161183 | 1 | 1 |
| 2026-08-25 | 4 | xslF345X06/form4-08252026_080833.xml | 0001327111-26-000006 | 4871 | ||||||
| 2026-08-25 | 4 | xslF345X06/form4-08252026_080813.xml | 0001866154-26-000006 | 4929 | ||||||
| 2026-08-25 | 4 | xslF345X06/form4-08252026_080815.xml | 0001907345-26-000006 | 4907 | ||||||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097073 | 005-93402 | 261281050 | 34 | 21429 | |||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080848.xml | 0002095702-26-000005 | 5399 | ||||||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080834.xml | 0001907345-26-000004 | 5355 | ||||||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080811.xml | 0001866154-26-000004 | 5377 | ||||||
| 2026-08-11 | 4 | xslF345X06/form4-08112026_080842.xml | 0001327111-26-000004 | 5319 | ||||||
| 2026-08-06 | 10-Q | 10-Q | 0001628280-26-054367 | 001-40502 | 261249572 | 34 | 11361534 | 1 | 1 | |
| 2026-08-06 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-054330 | 001-40502 | 261249240 | 34 | 321846 | 1 | 1 |
| 2026-07-27 | 4 | FORM 4 | 0001140361-26-029817 | 5560 | ||||||
| 2026-07-27 | 4 | FORM 4 | 0001140361-26-029791 | 5568 | ||||||
| 2026-07-21 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002375 | 333-297433 | 261191571 | 33 | 1724 | ||
| 2026-07-20 | 4 | FORM 4 | 0001140361-26-028955 | 5150 | ||||||
| 2026-07-17 | 4 | FORM 4 | 0001140361-26-028846 | 5151 | ||||||
| 2026-07-17 | CORRESP | filename1.htm | 0001193125-26-307470 | 7034 | ||||||
| 2026-07-16 | UPLOAD | filename1.pdf | 0000000000-26-007086 | 333-297433 | 147280 | |||||
| 2026-07-13 | S-3 | S-3 | 0001193125-26-302132 | 333-297433 | 261172000 | 33 | 353605 | 1 | 1 | |
| 2026-07-01 | 4 | FORM 4 | 0001140361-26-027140 | 5535 | ||||||
| 2026-06-18 | 4 | xslF345X06/form4.xml | 0001140361-26-025796 | 5529 | ||||||
| 2026-06-18 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001140361-26-025769 | 005-93402 | 261103256 | 34 | 9594 | |||
| 2026-06-18 | 3 | FORM 3 | 0001140361-26-025740 | 4813 | ||||||
| 2026-06-15 | 4 | xslF345X06/form4-06152026_100612.xml | 0001327111-26-000003 | 5319 | ||||||
| 2026-06-15 | 4 | xslF345X06/form4-06152026_100619.xml | 0001907345-26-000003 | 5535 | ||||||
| 2026-06-15 | 4 | xslF345X06/form4-06152026_100659.xml | 0001866154-26-000003 | 5555 | ||||||
| 2026-06-15 | 4 | xslF345X06/form4-06152026_100616.xml | 0002095702-26-000004 | 5399 | ||||||
| 2026-06-15 | 8-K | 8-K | 5.07 | 0001193125-26-271071 | 001-40502 | 261090790 | 34 | 147606 | 1 | 1 |
| 2026-06-12 | 4 | xslF345X06/form4-06122026_080603.xml | 0001182471-26-000002 | 5897 | ||||||
| 2026-06-12 | 4 | xslF345X06/form4-06122026_080637.xml | 0001439368-26-000002 | 7021 | ||||||
| 2026-06-12 | 4 | xslF345X06/form4-06122026_080608.xml | 0001619929-26-000004 | 5864 | ||||||
| 2026-06-12 | 4 | xslF345X06/form4-06122026_080656.xml | 0001591178-26-000002 | 8357 | ||||||
| 2026-06-12 | 4 | xslF345X06/form4-06122026_080616.xml | 0001411874-26-000002 | 8542 | ||||||
| 2026-06-12 | 4 | xslF345X06/form4-06122026_080623.xml | 0001213029-26-000007 | 6760 | ||||||
| 2026-06-12 | 4 | xslF345X06/form4-06122026_080602.xml | 0001887762-26-000002 | 5891 | ||||||
| 2026-06-11 | 4 | xslF345X06/form4-06112026_080646.xml | 0001959742-26-000002 | 5069 | ||||||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001012975-26-000439 | 005-93402 | 26986937 | 34 | 27948 | |||
| 2026-05-11 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-216076 | 005-93402 | 26961539 | 34 | 9115 | |||
| 2026-05-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001168404-26-000021 | 005-93402 | 26958750 | 34 | 10992 | |||
| 2026-05-06 | 10-Q | 10-Q | 0001628280-26-031284 | 001-40502 | 26948597 | 34 | 10459969 | 1 | 1 | |
| 2026-05-06 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-031269 | 001-40502 | 26948457 | 34 | 291048 | 1 | 1 |
| 2026-04-24 | ARS | ARS | 0001140361-26-016690 | 001-40502 | 26893706 | 34 | 4158610 | |||
| 2026-04-24 | DEFA14A | DEFA14A | 0001140361-26-016688 | 001-40502 | 26893684 | 34 | 1211663 | |||
| 2026-04-24 | DEF 14A | DEF 14A | 0001140361-26-016686 | 001-40502 | 26893581 | 34 | 5003477 | 1 | 1 | |
| 2026-04-21 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-165277 | 005-93402 | 26876884 | 34 | 11403 | |||
| 2026-04-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001185 | 333-294884 | 26862414 | 33 | 1723 | ||
| 2026-04-13 | CORRESP | filename1.htm | 0001193125-26-151895 | 7083 | ||||||
| 2026-04-08 | UPLOAD | filename1.pdf | 0000000000-26-003547 | 333-294884 | 40023 | |||||
| 2026-04-03 | S-3 | S-3 | 0001193125-26-142213 | 333-294884 | 26838419 | 33 | 324312 | 1 | 1 | |
| 2026-03-16 | 4 | xslF345X05/form4-03162026_110321.xml | 0001808821-26-000006 | 5498 | ||||||
| 2026-03-16 | 3 | xslF345X02/form3-03162026_110346.xml | 0001808821-26-000005 | 9289 | ||||||
| 2026-03-12 | S-8 | S-8 | 0001193125-26-104336 | 333-294257 | 26748607 | 33 | 202666 | 1 | 1 | |
| 2026-03-12 | 10-K | 10-K | 0001628280-26-017253 | 001-40502 | 26747964 | 34 | 18792604 | 1 | 1 | |
| 2026-03-12 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-017244 | 001-40502 | 26747834 | 34 | 291398 | 1 | 1 |
| 2026-03-09 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000235 | 16418 | ||||||
| 2026-03-09 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000234 | 21440 | ||||||
| 2026-03-09 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-097615 | 001-40502 | 26733257 | 34 | 200857 | 1 | 1 |
| 2026-02-12 | 4 | xslF345X05/form4-02132026_010246.xml | 0001327111-26-000002 | 5204 | ||||||
| 2026-02-12 | 4 | xslF345X05/form4-02132026_010228.xml | 0001866154-26-000002 | 5263 | ||||||
| 2026-02-12 | 4 | xslF345X05/form4-02132026_010253.xml | 0001907345-26-000002 | 5240 | ||||||
| 2026-02-11 | 4 | xslF345X05/form4-02122026_020218.xml | 0001866154-26-000001 | 9686 | ||||||
| 2026-02-11 | 4 | xslF345X05/form4-02122026_020216.xml | 0001907345-26-000001 | 9663 | ||||||
| 2026-02-11 | 4 | xslF345X05/form4-02122026_020200.xml | 0001327111-26-000001 | 9450 | ||||||
| 2026-02-11 | 4 | xslF345X05/form4-02122026_020247.xml | 0001771329-26-000001 | 5962 | ||||||
| 2026-02-11 | 4 | xslF345X05/form4-02122026_020223.xml | 0002095702-26-000002 | 6731 | ||||||
| 2026-02-11 | 4 | xslF345X05/form4-02122026_010247.xml | 0001959742-26-000001 | 6622 | ||||||
| 2026-01-06 | 4 | xslF345X05/form4-01062026_090153.xml | 0002095702-26-000001 | 6544 | ||||||
| 2025-12-18 | 424B5 | 424B5 | 0001193125-25-324801 | 333-291970 | 251583063 | 33 | 243337 | |||
| 2025-12-15 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003741 | 333-291970 | 251573263 | 33 | 1724 | ||
| 2025-12-11 | CORRESP | filename1.htm | 0001193125-25-315941 | 7227 | ||||||
| 2025-12-08 | 8-K | 8-K | 8.01 | 0001193125-25-310469 | 001-40502 | 251554515 | 34 | 145452 | 1 | 1 |
| 2025-12-05 | S-3 | S-3 | 0001193125-25-309779 | 333-291970 | 251553486 | 33 | 581920 | 1 | 1 | |
| 2025-12-05 | 8-K | 8-K | 5.03,9.01 | 0001193125-25-309621 | 001-40502 | 251552944 | 34 | 373493 | 1 | 1 |
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001012975-25-000768 | 005-93402 | 251487015 | 34 | 65627 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-112479 | 005-93402 | 251485824 | 34 | 22825 | |||
| 2025-11-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001140361-25-042006 | 005-93402 | 251479627 | 34 | 6761 | |||
| 2025-11-12 | 4 | xslF345X05/form4-11132025_011139.xml | 0001327111-25-000007 | 4733 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11132025_011155.xml | 0002095702-25-000003 | 5261 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11132025_011126.xml | 0001907345-25-000006 | 4751 | ||||||
| 2025-11-12 | 4 | xslF345X05/form4-11132025_011153.xml | 0001866154-25-000006 | 4791 | ||||||
| 2025-11-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-25-277861 | 005-93402 | 251473919 | 34 | 10941 | |||
| 2025-11-12 | 10-Q | 10-Q | 0001628280-25-051619 | 001-40502 | 251473098 | 34 | 10845034 | 1 | 1 | |
| 2025-11-12 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-051603 | 001-40502 | 251472846 | 34 | 294015 | 1 | 1 |
| 2025-11-10 | 3 | xslF345X02/form3-11112025_021155.xml | 0002095702-25-000002 | 14567 | ||||||
| 2025-11-10 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-25-273269 | 001-40502 | 251464357 | 34 | 178312 | 1 | 1 |
| 2025-11-03 | 8-K | 8-K | 5.02 | 0001193125-25-261753 | 001-40502 | 251442227 | 34 | 134520 | 1 | 1 |
| 2025-10-29 | 4 | xslF345X05/form4-10292025_091048.xml | 0001866154-25-000005 | 12265 | ||||||
| 2025-10-29 | 4 | xslF345X05/form4-10292025_091031.xml | 0001907345-25-000005 | 12248 | ||||||
| 2025-10-29 | 4 | xslF345X05/form4-10292025_091010.xml | 0001327111-25-000006 | 12205 | ||||||
| 2025-09-16 | 8-K | 8-K | 5.02 | 0001193125-25-205020 | 001-40502 | 251317580 | 34 | 132779 | 1 | 1 |
| 2025-08-22 | 4 | xslF345X05/form4-08222025_080818.xml | 0001415889-25-022747 | 7169 | ||||||
| 2025-08-22 | 4 | xslF345X05/form4-08222025_080857.xml | 0001415889-25-022746 | 7225 | ||||||
| 2025-08-22 | 4 | xslF345X05/form4-08222025_080821.xml | 0001415889-25-022741 | 8082 | ||||||
| 2025-08-22 | 4 | xslF345X05/form4-08222025_080803.xml | 0001415889-25-022740 | 7202 | ||||||
| 2025-08-19 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-022288 | 005-93402 | 251231882 | 34 | 15440 | |||
| 2025-08-15 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002652 | 333-289539 | 251226170 | 33 | 1724 | ||
| 2025-08-13 | 4 | xslF345X05/form4-08142025_010843.xml | 0001415889-25-021694 | 7778 | ||||||
| 2025-08-13 | 4 | xslF345X05/form4-08142025_010830.xml | 0001415889-25-021693 | 8011 | ||||||
| 2025-08-13 | 4 | xslF345X05/form4-08142025_010810.xml | 0001415889-25-021692 | 7990 | ||||||
| 2025-08-13 | 4 | xslF345X05/form4-08142025_010858.xml | 0001415889-25-021691 | 8888 | ||||||
| 2025-08-13 | CORRESP | filename1.htm | 0001193125-25-179830 | 7077 | ||||||
| 2025-08-13 | UPLOAD | filename1.pdf | 0000000000-25-008503 | 333-289539 | 40037 | |||||
| 2025-08-12 | S-3 | S-3 | 0001193125-25-179042 | 333-289539 | 251207539 | 33 | 340850 | 1 | 1 | |
| 2025-08-12 | 10-Q | 10-Q | 0001806952-25-000008 | 001-40502 | 251206848 | 34 | 10124159 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 2.02,9.01 | 0001806952-25-000007 | 001-40502 | 251206777 | 34 | 286077 | 1 | 1 |
| 2025-08-01 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-073122 | 005-93402 | 251176374 | 34 | 17199 | |||
| 2025-07-31 | 424B5 | 424B5 | 0001193125-25-170528 | 333-288769 | 251171798 | 33 | 457346 | |||
| 2025-07-30 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002413 | 333-288769 | 251169104 | 33 | 1724 | ||
| 2025-07-29 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-013262 | 18443 | ||||||
| 2025-07-29 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-013261 | 15997 | ||||||
| 2025-07-28 | CORRESP | filename1.htm | 0001193125-25-166426 | 6781 | ||||||
| 2025-07-25 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-25-164853 | 001-40502 | 251148637 | 34 | 523668 | 1 | 1 |
| 2025-07-23 | UPLOAD | filename1.pdf | 0000000000-25-007760 | 333-288769 | 40063 | |||||
| 2025-07-18 | S-3 | S-3 | 0001193125-25-161227 | 333-288769 | 251134739 | 33 | 721647 | 1 | 1 | |
| 2025-06-26 | 8-K | 8-K | 3.02 | 0001193125-25-148897 | 001-40502 | 251080418 | 34 | 134564 | 1 | 1 |
| 2025-06-17 | 8-K | 8-K | 8.01 | 0001193125-25-141795 | 001-40502 | 251052004 | 34 | 147570 | 1 | 1 |
| 2025-06-11 | 4 | xslF345X05/form4-06112025_090624.xml | 0001415889-25-016730 | 5603 | ||||||
| 2025-06-11 | 4 | xslF345X05/form4-06112025_090608.xml | 0001415889-25-016729 | 5533 | ||||||
| 2025-06-11 | 4 | xslF345X05/form4-06112025_090645.xml | 0001415889-25-016728 | 7402 | ||||||
| 2025-06-11 | 3 | xslF345X02/form3-06112025_090624.xml | 0001415889-25-016727 | 9285 | ||||||
| 2025-06-11 | 3 | xslF345X02/form3-06112025_090646.xml | 0001415889-25-016726 | 9283 | ||||||
| 2025-06-11 | 3 | xslF345X02/form3-06112025_090654.xml | 0001415889-25-016725 | 9272 | ||||||
| 2025-06-09 | 8-K | 8-K | 5.02 | 0001193125-25-137853 | 001-40502 | 251034420 | 34 | 134235 | 1 | 1 |
| 2025-05-28 | 8-K | 8-K | 3.03,9.01 | 0001193125-25-129448 | 001-40502 | 25995293 | 34 | 150854 | 1 | 1 |
| 2025-05-21 | 8-K | 8-K | 5.07 | 0001193125-25-123970 | 001-40502 | 25973124 | 34 | 147792 | 1 | 1 |
| 2025-05-19 | 4 | xslF345X05/form4-05192025_100514.xml | 0001415889-25-013723 | 7957 | ||||||
| 2025-05-19 | 4 | xslF345X05/form4-05192025_100545.xml | 0001415889-25-013719 | 5771 | ||||||
| 2025-05-19 | 4 | xslF345X05/form4-05192025_100556.xml | 0001415889-25-013712 | 8134 | ||||||
| 2025-05-19 | 4 | xslF345X05/form4-05192025_100517.xml | 0001415889-25-013710 | 6395 | ||||||
| 2025-05-19 | 4 | xslF345X05/form4-05192025_100536.xml | 0001415889-25-013707 | 5738 | ||||||
| 2025-05-19 | 4 | xslF345X05/form4-05192025_100544.xml | 0001415889-25-013705 | 6657 | ||||||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-049403 | 005-93402 | 25952592 | 34 | 22943 | |||
| 2025-05-13 | 10-Q | 10-Q | 0001628280-25-025135 | 001-40502 | 25940862 | 34 | 12180846 | 1 | 1 | |
| 2025-05-13 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-025128 | 001-40502 | 25940841 | 34 | 268710 | 1 | 1 |
| 2025-04-21 | ARS | ARS | 0001140361-25-014722 | 001-40502 | 25853189 | 34 | 5446695 | |||
| 2025-04-21 | DEF 14A | DEF 14A | 0001140361-25-014721 | 001-40502 | 25853171 | 34 | 5610937 | 1 | 1 | |
| 2025-04-10 | PRE 14A | PRE 14A | 0001140361-25-013293 | 001-40502 | 25829072 | 34 | 5595263 | 1 | 1 | |
| 2025-04-02 | 4 | xslF345X05/form4-04022025_070458.xml | 0001415889-25-009604 | 4528 | ||||||
| 2025-04-01 | 8-K | 8-K | 2.05,5.02,7.01 | 0001193125-25-070521 | 001-40502 | 25800668 | 34 | 151227 | 1 | 1 |
| 2025-03-25 | 4 | xslF345X05/form4-03252025_100313.xml | 0001415889-25-008942 | 5347 | ||||||
| 2025-03-18 | 4 | xslF345X05/form4-03192025_120347.xml | 0001415889-25-008540 | 6650 | ||||||
| 2025-03-18 | 4 | xslF345X05/form4-03182025_110331.xml | 0001415889-25-008517 | 6037 | ||||||
| 2025-03-18 | 4 | xslF345X05/form4-03182025_100315.xml | 0001415889-25-008509 | 5108 | ||||||
| 2025-03-11 | S-8 | S-8 | 0001193125-25-051999 | 333-285717 | 25728366 | 33 | 79000 | |||
| 2025-03-11 | 10-K | 10-K | 0001628280-25-011978 | 001-40502 | 25727736 | 34 | 16197247 | 1 | 1 | |
| 2025-03-11 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-011960 | 001-40502 | 25727605 | 34 | 306087 | 1 | 1 |
| 2025-02-26 | 4 | xslF345X05/form4-02272025_120200.xml | 0001415889-25-005775 | 9672 | ||||||
| 2025-02-26 | 4 | xslF345X05/form4-02272025_120243.xml | 0001415889-25-005768 | 9656 | ||||||
| 2025-02-26 | 4 | xslF345X05/form4-02272025_120219.xml | 0001415889-25-005760 | 9937 | ||||||
| 2025-02-26 | 4 | xslF345X05/form4-02272025_120230.xml | 0001415889-25-005753 | 9873 | ||||||
| 2025-02-26 | 4 | xslF345X05/form4-02272025_120251.xml | 0001415889-25-005747 | 9913 | ||||||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001072613-25-000168 | 005-93402 | 25630386 | 34 | 35397 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-013912 | 005-93402 | 25626729 | 34 | 23118 | |||
| 2025-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-001224 | 005-93402 | 25592232 | 34 | 11764 | |||
| 2025-01-24 | 8-K | 8-K | 3.01 | 0001193125-25-012249 | 001-40502 | 25554681 | 34 | 146797 | 1 | 1 |
| 2025-01-10 | 8-K/A | 8-K/A | 9.01 | 0001628280-25-001065 | 001-40502 | 25520734 | 34 | 1424813 | 1 | 1 |
| 2024-12-10 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-273688 | 001-40502 | 241536881 | 34 | 169851 | 1 | 1 |
| 2024-12-09 | 424B5 | 424B5 | 0001193125-24-272943 | 333-283533 | 241533958 | 33 | 548686 | |||
| 2024-12-05 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-12-05 16:00:00 | 9999999995-24-003682 | 333-283533 | 241530412 | 33 | 1731 | ||
| 2024-12-03 | CORRESP | filename1.htm | 0001193125-24-269995 | 6839 | ||||||
| 2024-12-03 | UPLOAD | filename1.pdf | 0000000000-24-013301 | 333-283533 | 40116 | |||||
| 2024-11-29 | S-3 | S-3 | 0001193125-24-268106 | 333-283533 | 241516560 | 33 | 815354 | 1 | 1 | |
| 2024-11-26 | 8-K | 8-K | 5.02 | 0001193125-24-266101 | 001-40502 | 241503675 | 34 | 140117 | 1 | 1 |
| 2024-11-12 | SC 13G/A | UnitedStates_13G__LyellImmun.txt | 0000932471-24-001105 | 005-93402 | 241447889 | 34 | 6525 | |||
| 2024-11-07 | 10-Q | 10-Q | 0001628280-24-046285 | 001-40502 | 241435996 | 34 | 7960593 | 1 | 1 | |
| 2024-11-07 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-046254 | 001-40502 | 241435687 | 34 | 285273 | 1 | 1 |
| 2024-11-04 | SC 13G/A | UnitedStates_13G__LyellImmun.txt | 0000932471-24-000620 | 005-93402 | 241422218 | 34 | 5581 | |||
| 2024-11-01 | 4 | xslF345X05/form4-11012024_081136.xml | 0001415889-24-025912 | 5583 | ||||||
| 2024-11-01 | 3 | xslF345X02/form3-11012024_081129.xml | 0001415889-24-025909 | 9071 | ||||||
| 2024-10-31 | SC 13G | SC 13G | 0001104659-24-113135 | 005-93402 | 241416467 | 34 | 134104 | |||
| 2024-10-31 | 8-K | 8-K | 1.01,2.01,5.02,7.01,9.01 | 0001193125-24-248760 | 001-40502 | 241415848 | 34 | 328822 | 1 | 1 |
| 2024-10-24 | 8-K | 8-K | 1.01,3.02,7.01,8.01,9.01 | 0001193125-24-242808 | 001-40502 | 241392663 | 34 | 1007113 | 1 | 1 |
| 2024-08-07 | 10-Q | 10-Q | 0001628280-24-035617 | 001-40502 | 241183765 | 34 | 7386383 | 1 | 1 | |
| 2024-08-07 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-035603 | 001-40502 | 241183649 | 34 | 290655 | 1 | 1 |
| 2024-06-26 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-168597 | 001-40502 | 241070704 | 34 | 15782685 | 1 | 1 |
| 2024-06-17 | 4 | xslF345X05/form4-06172024_080644.xml | 0001415889-24-017220 | 14921 | ||||||
| 2024-06-17 | 4 | xslF345X05/form4-06172024_080643.xml | 0001415889-24-017183 | 12540 | ||||||
| 2024-06-17 | 4 | xslF345X05/form4-06172024_080654.xml | 0001415889-24-017176 | 14574 | ||||||
| 2024-06-17 | 4 | xslF345X05/form4-06172024_080620.xml | 0001415889-24-017162 | 11914 | ||||||
| 2024-06-17 | 4 | xslF345X05/form4-06172024_080605.xml | 0001415889-24-017152 | 11896 | ||||||
| 2024-06-17 | 4 | xslF345X05/form4-06172024_080619.xml | 0001415889-24-017147 | 11859 | ||||||
| 2024-06-17 | 4 | xslF345X05/form4-06172024_080617.xml | 0001415889-24-017146 | 14280 | ||||||
| 2024-06-14 | 8-K | 8-K | 5.07 | 0001193125-24-161601 | 001-40502 | 241044768 | 34 | 153302 | 1 | 1 |
| 2024-05-06 | 424B5 | 424B5 | 0001193125-24-131492 | 333-277495 | 24915654 | 33 | 495263 | |||
| 2024-05-06 | 10-Q | 10-Q | 0001628280-24-020467 | 001-40502 | 24915647 | 34 | 6554073 | 1 | 1 | |
| 2024-05-06 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-020466 | 001-40502 | 24915638 | 34 | 257075 | 1 | 1 |
| 2024-05-03 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-05-03 16:30:00 | 9999999995-24-001369 | 333-277495 | 24915364 | 33 | 1730 | ||
| 2024-05-01 | CORRESP | filename1.htm | 0001193125-24-127548 | 7313 | ||||||
| 2024-04-22 | ARS | ARS | 0001140361-24-021014 | 001-40502 | 24861400 | 34 | 2964761 | |||
| 2024-04-22 | DEFA14A | DEFA14A | 0001140361-24-021011 | 001-40502 | 24861387 | 34 | 1220414 | |||
| 2024-04-22 | DEF 14A | DEF 14A | 0001140361-24-021008 | 001-40502 | 24861371 | 34 | 5631876 | 1 | 1 | |
| 2024-03-04 | UPLOAD | filename1.pdf | 0000000000-24-002403 | 333-277495 | 40270 | |||||
| 2024-02-29 | S-3 | S-3 | 0001193125-24-051177 | 333-277495 | 24698182 | 33 | 1426104 | |||
| 2024-02-29 | S-8 | S-8 | 0001193125-24-051169 | 333-277494 | 24698155 | 33 | 84640 | |||
| 2024-02-28 | 10-K | 10-K | 0001628280-24-007592 | 001-40502 | 24695507 | 34 | 14201141 | 1 | 1 | |
| 2024-02-28 | 8-K | 8-K | 2.02,9.01 | 0001628280-24-007579 | 001-40502 | 24695285 | 34 | 299261 | 1 | 1 |
| 2024-02-14 | SC 13G/A | ARCH VENTURE FUND IX, L.P. - LYELL IMMUNOPHARMA -- SCH 13G/A(#1) | 0001072613-24-000252 | 005-93402 | 24636717 | 34 | 277144 | |||
| 2024-02-13 | 4 | FORM 4 SUBMISSION | 0001209191-24-003276 | 7425 | ||||||
| 2024-02-13 | 4 | FORM 4 SUBMISSION | 0001209191-24-003274 | 11107 | ||||||
| 2024-02-13 | 4 | FORM 4 SUBMISSION | 0001209191-24-003272 | 11083 | ||||||
| 2024-02-13 | 4 | FORM 4 SUBMISSION | 0001209191-24-003270 | 11030 | ||||||
| 2024-02-13 | 4 | FORM 4 SUBMISSION | 0001209191-24-003269 | 4991 | ||||||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021383 | 005-93402 | 24628870 | 34 | 13026 | |||
| 2024-01-29 | SC 13G | us55083r1041_012924.txt | 0001086364-24-005606 | 005-93402 | 24574940 | 34 | 13556 | |||
| 2023-11-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-056181 | 24351 | ||||||
| 2023-11-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-056180 | 9995 | ||||||
| 2023-11-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-056179 | 9030 | ||||||
| 2023-11-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-056178 | 33842 | ||||||
| 2023-11-20 | 8-K | 8-K | 5.02 | 0001193125-23-280680 | 001-40502 | 231423107 | 34 | 144689 | 1 | 1 |
| 2023-11-07 | 10-Q | 10-Q | 0001628280-23-037360 | 001-40502 | 231384092 | 34 | 8538263 | 1 | 1 | |
| 2023-11-07 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-037346 | 001-40502 | 231383748 | 34 | 292827 | 1 | 1 |
| 2023-09-11 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-232064 | 001-40502 | 231246956 | 34 | 13719461 | 1 | 1 |
| 2023-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-048788 | 8017 | ||||||
| 2023-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-048786 | 6201 | ||||||
| 2023-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-048785 | 8675 | ||||||
| 2023-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-048784 | 9273 | ||||||
| 2023-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-048783 | 6178 | ||||||
| 2023-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-048782 | 6144 | ||||||
| 2023-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-048779 | 6771 | ||||||
| 2023-08-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-046267 | 6293 | ||||||
| 2023-08-15 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000125 | 001-40502 | 231174602 | 33 | 4163 | |||
| 2023-08-15 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000124 | 001-40502 | 231174590 | 33 | 4163 | |||
| 2023-08-15 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000123 | 001-40502 | 231174563 | 33 | 4165 | |||
| 2023-08-15 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000122 | 001-40502 | 231174553 | 33 | 4163 | |||
| 2023-08-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-045439 | 5389 | ||||||
| 2023-08-08 | 10-Q | 10-Q | 0001628280-23-028215 | 001-40502 | 231151734 | 34 | 7201258 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-028189 | 001-40502 | 231151383 | 34 | 291813 | 1 | 1 |
| 2023-07-20 | 3 | FORM 3 SUBMISSION | 0001209191-23-042866 | 6295 | ||||||
| 2023-07-17 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000092 | 001-40502 | 231092523 | 33 | 4225 | |||
| 2023-07-17 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000091 | 001-40502 | 231092519 | 33 | 4223 | |||
| 2023-07-17 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000090 | 001-40502 | 231092506 | 33 | 4223 | |||
| 2023-07-17 | 144 | xsl144X01/primary_doc.xml | 0001974078-23-000089 | 001-40502 | 231092497 | 33 | 4223 | |||
| 2023-06-21 | 8-K | 8-K | 5.07 | 0001193125-23-171240 | 001-40502 | 231030581 | 34 | 160236 | 1 | 1 |
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038449 | 5691 | ||||||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038445 | 8762 | ||||||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038441 | 5667 | ||||||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038439 | 7510 | ||||||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038437 | 8165 | ||||||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038435 | 5633 | ||||||
| 2023-06-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-038433 | 6261 | ||||||
| 2023-06-06 | 8-K | 8-K | 5.02 | 0001193125-23-161594 | 001-40502 | 23996049 | 34 | 144211 | 1 | 1 |
| 2023-05-04 | 10-Q | 10-Q | 0001628280-23-015765 | 001-40502 | 23889072 | 34 | 6695877 | 1 | 1 | |
| 2023-05-04 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-015733 | 001-40502 | 23888819 | 34 | 278322 | 1 | 1 |
| 2023-04-28 | ARS | ARS | 0001140361-23-021541 | 001-40502 | 23866239 | 34 | 2093360 | |||
| 2023-04-27 | DEFA14A | FORM DEFA14A | 0001140361-23-020926 | 001-40502 | 23856875 | 34 | 1072219 | |||
| 2023-04-27 | DEF 14A | DEF 14A | 0001140361-23-020919 | 001-40502 | 23856836 | 34 | 5466167 | 1 | 1 | |
| 2023-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-013850 | 6182 | ||||||
| 2023-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-013848 | 6225 | ||||||
| 2023-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-013844 | 6159 | ||||||
| 2023-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-013839 | 5356 | ||||||
| 2023-02-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-013836 | 6115 | ||||||
| 2023-02-28 | S-8 | S-8 | 0001193125-23-054284 | 333-270145 | 23687630 | 33 | 79737 | |||
| 2023-02-28 | 10-K | 10-K | 0001628280-23-005572 | 001-40502 | 23685778 | 34 | 12923536 | 1 | 1 | |
| 2023-02-28 | 8-K | 8-K | 2.02,9.01 | 0001628280-23-005554 | 001-40502 | 23685377 | 34 | 312345 | 1 | 1 |
| 2023-02-13 | SC 13G/A | SC 13G/A | 0001104659-23-019827 | 005-93402 | 23619644 | 34 | 78846 | |||
| 2023-02-09 | SC 13G | SCHEDULE 13G | 0001104659-23-016396 | 005-93402 | 23603626 | 34 | 12915 | |||
| 2022-12-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-061898 | 5498 | ||||||
| 2022-12-16 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-307296 | 001-40502 | 221467886 | 34 | 299393 | 1 | 1 |
| 2022-11-08 | 10-Q | 10-Q | 0001628280-22-028929 | 001-40502 | 221369154 | 34 | 8966933 | 1 | 1 | |
| 2022-11-08 | 8-K | 8-K | 2.02,9.01 | 0001628280-22-028908 | 001-40502 | 221368919 | 34 | 305975 | 1 | 1 |
| 2022-10-24 | 8-K | 8-K | 1.02 | 0001628280-22-026904 | 001-40502 | 221326590 | 34 | 183487 | 1 | 1 |
| 2022-10-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-053457 | 5360 | ||||||
| 2022-10-06 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-258907 | 001-40502 | 221298511 | 34 | 175031 | 1 | 1 |
| 2022-10-03 | 3 | FORM 3 SUBMISSION | 0001209191-22-051817 | 6258 | ||||||
| 2022-09-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-051379 | 5688 | ||||||
| 2022-09-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-049299 | 6991 | ||||||
| 2022-08-04 | S-3ASR | S-3ASR | 0001193125-22-212689 | 333-266548 | 221137877 | 33 | 1405369 | |||
| 2022-08-04 | 10-Q | 10-Q | 0001628280-22-021109 | 001-40502 | 221137244 | 34 | 9020452 | 1 | 1 | |
| 2022-08-04 | 8-K | 8-K | 2.02,9.01 | 0001628280-22-021080 | 001-40502 | 221136778 | 34 | 298926 | 1 | 1 |
| 2022-06-13 | 8-K | 8-K | 5.07 | 0001193125-22-172997 | 001-40502 | 221012293 | 34 | 152029 | 1 | 1 |
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-035879 | 5657 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-035872 | 8728 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-035866 | 5608 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-035858 | 5633 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-035853 | 5599 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-035846 | 6227 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-035837 | 8131 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-035825 | 7338 | ||||||
| 2022-05-10 | 10-Q | 10-Q | 0001628280-22-013611 | 001-40502 | 22910202 | 34 | 8226412 | 1 | 1 | |
| 2022-05-10 | 8-K | 8-K | 2.02,9.01 | 0001628280-22-013590 | 001-40502 | 22909765 | 34 | 274802 | 1 | 1 |
| 2022-04-28 | DEF 14A | DEF 14A | 0001140361-22-016525 | 001-40502 | 22866657 | 34 | 2188954 | |||
| 2022-03-29 | 3 | FORM 3 SUBMISSION | 0001209191-22-021496 | 9934 | ||||||
| 2022-03-29 | S-8 | S-8 | 0001193125-22-088224 | 333-263952 | 22781702 | 33 | 85992 | |||
| 2022-03-29 | 10-K | 10-K | 0001628280-22-007708 | 001-40502 | 22781108 | 34 | 17754606 | 1 | 1 | |
| 2022-03-29 | 8-K | 8-K | 2.02,9.01 | 0001628280-22-007701 | 001-40502 | 22780940 | 34 | 317289 | 1 | 1 |
| 2022-03-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-020008 | 5324 | ||||||
| 2022-03-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-020006 | 5399 | ||||||
| 2022-03-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-020004 | 5400 | ||||||
| 2022-03-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-020001 | 5400 | ||||||
| 2022-02-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-013118 | 6991 | ||||||
| 2022-02-15 | 8-K | 8-K | 5.02 | 0001193125-22-043467 | 001-40502 | 22639832 | 34 | 158319 | 1 | 1 |
| 2022-02-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-009580 | 5373 | ||||||
| 2022-02-14 | SC 13G | SC 13G | 0001193125-22-041763 | 005-93402 | 22632270 | 34 | 49023 | |||
| 2022-02-14 | SC 13G | SC 13G | 0001193125-22-041692 | 005-93402 | 22631859 | 34 | 79703 | |||
| 2022-02-14 | SC 13G | ARCH VENTURE FUND IX, L.P. - LYELL IMMUNOPHARMA -- SCH 13G | 0001072613-22-000148 | 005-93402 | 22627825 | 34 | 270276 | |||
| 2022-02-11 | SC 13G | SC 13G | 0001104659-22-020368 | 005-93402 | 22619981 | 34 | 71182 | |||
| 2022-02-10 | SC 13G | SCHEDULE 13G | 0001387131-22-001554 | 005-93402 | 22614900 | 34 | 26587 | |||
| 2022-02-04 | 3 | FORM 3 SUBMISSION | 0001209191-22-007155 | 6353 | ||||||
| 2021-12-17 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-21-361060 | 001-40502 | 211501444 | 34 | 203979 | 1 | 1 |
| 2021-12-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-069485 | 8134 | ||||||
| 2021-12-03 | 8-K | 8-K | 8.01 | 0001193125-21-346888 | 001-40502 | 211467989 | 34 | 143448 | 1 | 1 |
| 2021-11-12 | 10-Q | 10-Q | 0000950170-21-004270 | 001-40502 | 211399931 | 34 | 10081106 | 1 | 1 | |
| 2021-11-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-004264 | 001-40502 | 211399866 | 34 | 620429 | 1 | 1 |
| 2021-10-28 | 8-K | 8-K | 5.02 | 0001193125-21-309692 | 001-40502 | 211354534 | 34 | 146697 | 1 | 1 |
| 2021-10-01 | 8-K/A | 8-K/A | 5.02 | 0001193125-21-288697 | 001-40502 | 211296957 | 34 | 150559 | 1 | 1 |
| 2021-09-30 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-287960 | 001-40502 | 211295136 | 34 | 155091 | 1 | 1 |
| 2021-09-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-055899 | 5341 | ||||||
| 2021-08-12 | 10-Q | 10-Q | 0000950170-21-001389 | 001-40502 | 211168586 | 34 | 9201440 | 1 | 1 | |
| 2021-08-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-001370 | 001-40502 | 211167821 | 34 | 570901 | 1 | 1 |
| 2021-06-23 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001387131-21-006822 | 7839 | ||||||
| 2021-06-23 | 4 | FORM 4 SUBMISSION | 0000899243-21-025523 | 27004 | ||||||
| 2021-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-042801 | 18018 | ||||||
| 2021-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-042798 | 8218 | ||||||
| 2021-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-042796 | 6896 | ||||||
| 2021-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-042795 | 10967 | ||||||
| 2021-06-21 | S-8 | S-8 | 0001193125-21-195237 | 333-257249 | 211031743 | 33 | 543134 | |||
| 2021-06-21 | 424B4 | 424B4 | 0001193125-21-193519 | 333-256470 | 211026820 | 33 | 7179238 | |||
| 2021-06-17 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001387131-21-006635 | 5059 | ||||||
| 2021-06-16 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-06-16 16:00:00 | 9999999995-21-002371 | 333-256470 | 211023275 | 33 | 1738 | ||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0000899243-21-024324 | 19332 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-041113 | 9845 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-041112 | 7613 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-041111 | 7659 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-041110 | 10296 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-041108 | 13501 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-041107 | 7641 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-041104 | 12955 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-041102 | 12530 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-041100 | 12175 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-041096 | 7609 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-041094 | 9851 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-041093 | 12199 | ||||||
| 2021-06-16 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-003468 | 271684 | ||||||
| 2021-06-16 | CERT | 8A_Cert_LYEL.pdf | 0001354457-21-000669 | 001-40502 | 211020837 | 34 | 310843 | |||
| 2021-06-14 | 8-A12B | 8-A12B | 0001193125-21-190157 | 001-40502 | 211015237 | 34 | 13461 | |||
| 2021-06-14 | CORRESP | filename1.htm | 0001193125-21-190090 | 16132 | ||||||
| 2021-06-14 | CORRESP | filename1.htm | 0001193125-21-190080 | 7947 | ||||||
| 2021-06-09 | S-1/A | S-1/A | 0001193125-21-185918 | 333-256470 | 211003966 | 33 | 9071922 | |||
| 2021-06-07 | CORRESP | filename1.htm | 0001193125-21-183938 | 17721 | ||||||
| 2021-06-04 | UPLOAD | filename1.pdf | 0000000000-21-006981 | 43530 | ||||||
| 2021-06-01 | CORRESP | filename1.htm | 0001193125-21-178234 | 23558 | ||||||
| 2021-05-28 | CORRESP | filename1.htm | 0001193125-21-177261 | 129774 | ||||||
| 2021-05-28 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-003151 | 272665 | ||||||
| 2021-05-25 | UPLOAD | filename1.pdf | 0000000000-21-006587 | 44150 | ||||||
| 2021-05-25 | S-1 | S-1 | 0001193125-21-172500 | 333-256470 | 21961832 | 33 | 15405242 | |||
| 2021-05-12 | DRSLTR | filename1.htm | 0000950123-21-006100 | 44471 | ||||||
| 2021-05-12 | DRS/A | filename1.htm | 0000950123-21-006098 | 377-04650 | 21916248 | 33 | 7190348 | |||
| 2021-05-07 | UPLOAD | filename1.pdf | 0000000000-21-005899 | 55935 | ||||||
| 2021-04-12 | DRS | filename1.htm | 0000950123-21-004496 | 377-04650 | 21821435 | 33 | 14825360 | |||
| 2020-03-20 | D | xslFormDX01/primary_doc.xml | 06b | 0001806952-20-000001 | 021-363351 | 20731123 | 33 | 14783 |
One latest value per concept from companyfacts (252 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 24.59M | 2026-10-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 129.00M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 3.60M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001140361-26-016686 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 2.01M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001140361-26-016686 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 9.64M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001140361-26-016686 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 4.22M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001140361-26-016686 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 44.35 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001140361-26-016686 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 9,965.01 | 2026-11-13 | S-3 | 2026-11-13 | 0001193125-26-460585 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 9,965.01 | 2026-11-13 | S-3 | 2026-11-13 | 0001193125-26-460585 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 114.54M | 2026-11-13 | S-3 | 2026-11-13 | 0001193125-26-460585 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-13 | S-3 | 2026-11-13 | 0001193125-26-460585 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-11-13 | S-3 | 2026-11-13 | 0001193125-26-460585 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 4.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 2.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 11.15M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 42.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 670,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 74.28M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -278,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.93B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.49B | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004270 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 13.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 13.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 49.44M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001628280-22-021109 |
| us-gaap | AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable | AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable | USD | 33.97M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | AssetAcquisitionContingentConsiderationLiability | AssetAcquisitionContingentConsiderationLiability | USD | 7.60M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | AssetAcquisitionContingentConsiderationLiabilityCurrent | AssetAcquisitionContingentConsiderationLiabilityCurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | Assets | Assets | USD | 273.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 186.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 177.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 278,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 178.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | USD | 312.50M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004270 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | USD | 312.50M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004270 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 177.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 79,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 92.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 93.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 31.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 24.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 24.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 2,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -114.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0001628280-24-007592 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 194.47M | 2021-06-17 | 2023 | FY | 10-K | 2024-02-28 | 0001628280-24-007592 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 107.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 621.60M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001628280-22-021109 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 5.23M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxAssetsCapitalLossCarryforwards | Deferred Tax Assets, Capital Loss Carryforwards | USD | 14.59M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 936,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011978 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 30.11M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 434.18M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxAssetsInvestments | Deferred Tax Assets, Investments | USD | 7.76M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 5.23M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 242.84M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 819,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 10.76M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 42.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 7.89M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 3.07M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 428.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 5.23M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011978 | |
| us-gaap | DefinedBenefitPlanContributionsByEmployer | Defined Benefit Plan, Plan Assets, Contributions by Employer | USD | 1.20M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0001628280-24-007592 |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 800,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | Depreciation | Depreciation | USD | 10.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 6.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | DividendsPreferredStock | Dividends, Preferred Stock | USD | 1.14M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-29 | 0001628280-22-007708 |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 | |
| us-gaap | DueToRelatedPartiesNoncurrent | Due to Related Parties, Noncurrent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -4.93 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.66 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004270 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -4.93 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.196 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0.008 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.021 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.046 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.013 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 33.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | EquitySecuritiesFvNi | Equity Securities, FV-NI | USD | 1.07M | 2021-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 | |
| us-gaap | EquitySecuritiesFvNiCurrentAndNoncurrent | EquitySecuritiesFvNiCurrentAndNoncurrent | USD | 30,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | EquitySecuritiesFvNiUnrealizedGain | Equity Securities, FV-NI, Unrealized Gain | USD | 30,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011978 |
| us-gaap | EquitySecuritiesFvNiUnrealizedGainLoss | Equity Securities, FV-NI, Unrealized Gain (Loss) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | EquitySecuritiesFvNiUnrealizedLoss | Equity Securities, FV-NI, Unrealized Loss | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011978 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | USD | 0 | 2022-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0001628280-24-007592 | |
| us-gaap | FinancialLiabilitiesFairValueDisclosure | Financial Liabilities Fair Value Disclosure | USD | 227,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | -117,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | GainLossOnSaleOfOtherInvestments | Gain (Loss) on Sale of Other Investments | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011978 |
| us-gaap | GainLossOnTerminationOfLease | Gain (Loss) on Termination of Lease | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0001628280-24-007592 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 28.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | ImpairmentOfInvestments | Other than Temporary Impairment Losses, Investments | USD | 5.00M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001628280-22-028929 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 53.78M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -57.63M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | -2.31M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 5.83M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -14,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | -115,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 3.56M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 1.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 7.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011978 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -7.70M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004270 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-11 | 0001628280-25-011978 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 30,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -3.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 6.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 842,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004270 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 52.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 2.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 13.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 9.86M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 9.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 10.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 13.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 3.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 7.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | Liabilities | Liabilities | USD | 81.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 273.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 46.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 85.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 16.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 52.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 86.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -107.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -114.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -183.12M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 |
| us-gaap | NetRentableArea | Net Rentable Area | sqft | 11,000 | 2021-05-31 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001628280-22-021109 | |
| us-gaap | NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 | Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 25.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 139.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -139.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 6.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 44.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 9.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 34.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 9.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 15.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.085 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 2.56M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 5.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -49,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -520,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -520,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | OtherInvestments | Other Investments | USD | 19.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 547,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -324,000 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-12 | 0000950170-21-001389 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 19.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | OtherOperatingIncomeExpenseNet | Other Operating Income (Expense), Net | USD | 5.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 |
| us-gaap | PaymentsForRepurchaseOfPreferredStockAndPreferenceStock | Payments for Repurchase of Preferred Stock and Preference Stock | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 33.20M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0001628280-24-007592 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-06 | 0001628280-26-031284 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 134.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | PaymentsToAcquireOtherInvestments | Payments to Acquire Other Investments | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 411,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 9.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0001628280-24-007592 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 50.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 221.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 5,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 67,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 522,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 109.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 28.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff | Research and Development Asset Acquired Other than Through Business Combination, Written-off | USD | 66.33M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 117.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 158.68M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 466,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004270 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 1.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.25 | 2023-11-01 | 2023-11-30 | 2023 | FY | 10-K | 2024-02-28 | 0001628280-24-007592 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 5.52M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0001628280-24-007592 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.73B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | RevenueFromRelatedParties | Revenue from Related Parties | USD | 0 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-04 | 0001628280-23-015765 |
| us-gaap | Revenues | Revenues | USD | 9,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 |
| us-gaap | SaleAndLeasebackTransactionGainLossNet | Sale and Leaseback Transaction, Gain (Loss), Net | USD | 1.55M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 13.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.857 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.041 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 4.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 1.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 52.51 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 100,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 403,651 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 36.96 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 864,491 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 16.93 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 17.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 2.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 40.32 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 280.84M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004270 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 432.92M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004270 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | shares | 975,000 | 2021-04-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-12 | 0000950170-21-001389 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 11.07 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 14.25 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 192.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.05 | 2025-05-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 194.47M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-12 | 0000950170-21-001389 |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 543,000 | 2023-04-01 | 2023-06-30 | 2024 | Q2 | 10-Q | 2024-08-07 | 0001628280-24-035617 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 3,750 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 33.97M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 1.01B | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0001628280-24-007592 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 522,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 1.70M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-06 | 0001628280-26-031284 |
| us-gaap | StockIssuedDuringPeriodValuePurchaseOfAssets | Stock Issued During Period, Value, Purchase of Assets | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 1,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 62.20M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-29 | 0001628280-22-007708 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 67,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | StockRepurchasedDuringPeriodShares | Stock Repurchased During Period, Shares | shares | 2.03M | 2020-03-01 | 2020-03-31 | 2021 | Q2 | 10-Q | 2021-08-12 | 0000950170-21-001389 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 11.81M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 4.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 0 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-28 | 0001628280-24-007592 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-29 | 0001628280-22-007708 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-29 | 0001628280-22-007708 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-29 | 0001628280-22-007708 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | TransferToInvestments | Transfer to Investments | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0001628280-23-005572 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 3.46M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 202,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 1.63M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 69.51M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001628280-26-017253 |
| us-gaap | VariableInterestEntityEntityMaximumLossExposureAmount | Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 | |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 4.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 23.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 100,603 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0000950170-21-004270 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 23.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070171 |